These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20881384)

  • 1. From bench to bedside: report of the Sixth International Stroke Summit, Nanjing, China, July 9-11, 2010.
    Jiang Y; Xu G; Liu X
    Cerebrovasc Dis; 2010; 30(5):535. PubMed ID: 20881384
    [No Abstract]   [Full Text] [Related]  

  • 2. Focus on endovascular solutions for cerebrovascular diseases: report of the Fourth International Stroke Summit, Nanjing, China, July 25-27, 2008.
    Xu G; Cheng S; Liu X
    Cerebrovasc Dis; 2008; 26(6):667-8. PubMed ID: 19023199
    [No Abstract]   [Full Text] [Related]  

  • 3. A new antiplatelet agent cilostazol--what is the evidence for its use and tolerability?
    Sidddiqi SA; Kamal AK
    J Pak Med Assoc; 2012 Jan; 62(1):78-9. PubMed ID: 22352114
    [No Abstract]   [Full Text] [Related]  

  • 4. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 5. Missed opportunities to prevent stroke recurrence.
    Thrift AG; Kim J
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):773-4. PubMed ID: 20497418
    [No Abstract]   [Full Text] [Related]  

  • 6. Cilostazol research in Asia: can it be applied to European and American patients?
    Kim JS; Kwon SU; Uchiyama S
    Int J Stroke; 2015 Mar; 10 Suppl 1():1-9. PubMed ID: 25736819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of recurrent stroke.
    Hankey GJ
    Stroke; 2005 Feb; 36(2):218-21. PubMed ID: 15637323
    [No Abstract]   [Full Text] [Related]  

  • 8. Narrowing the gap of stroke management between developed and developing countries: report of the fifth international stroke summit, Nanjing, China, July 17-19, 2009.
    Xu G; Yin Q; Liu X
    Cerebrovasc Dis; 2010; 29(1):101-2. PubMed ID: 19923818
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 10. Early dual therapy for Chinese adults with TIA.
    BMJ; 2013 Jul; 347():f4197. PubMed ID: 23823995
    [No Abstract]   [Full Text] [Related]  

  • 11. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of atherothrombotic or cryptogenic stroke.
    Tai WA; Albers GW
    Circulation; 2014 Jan; 129(4):527-31. PubMed ID: 24470474
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Borja and Garcia-Rafanell regarding article, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".
    Borja J; García-Rafanell J
    Stroke; 2011 Jun; 42(6):e388; author reply e386. PubMed ID: 21546474
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy to prevent recurrent stroke: Three good options.
    Mansoor AH; Mujtaba MT; Silver B
    Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of stroke with aspirin, vitamin E is ineffective].
    Stiefelhagen P
    Med Monatsschr Pharm; 2005 Jul; 28(7):249-50. PubMed ID: 16038126
    [No Abstract]   [Full Text] [Related]  

  • 16. The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
    Hart RG
    Int J Stroke; 2011 Jun; 6(3):207-8. PubMed ID: 21557805
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
    Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
    Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke prevention: optimizing the response to a common threat.
    Toole JF; Sane DC; Bettermann K
    JAMA; 2004 Oct; 292(15):1885-7. PubMed ID: 15494588
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional differences in incidence and management of stroke - is there any difference between Western and Japanese guidelines on antiplatelet therapy?
    Shinohara Y
    Cerebrovasc Dis; 2006; 21 Suppl 1():17-24. PubMed ID: 16479098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of transient ischemic attack.
    Sylaja PN; Hill MD
    Am J Cardiovasc Drugs; 2007; 7(1):67-74. PubMed ID: 17355167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.